Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kanger Shen Pian
- Development stage
- Unknown
- Lead developer
- Lanzhou Institute of Chemical Physics
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Kanger Shen Pian is a Traditional Chinese Medicine (TCM) botanical drug candidate developed by the Lanzhou Institute of Chemical Physics of the Chinese Academy of Sciences. It is specifically designed for the treatment of chronic glomerulonephritis, particularly for patients presenting with the Damp-Heat and Blood Stasis syndrome (湿热瘀阻证) according to TCM diagnostic criteria. The medication is administered orally in tablet form. Clinical evaluation, including a Phase II trial (CTR20132145), has focused on its efficacy and safety in managing renal inflammation, reducing proteinuria, and improving clinical outcomes in chronic kidney disease patients.
- Brand names
- Kanger Shen Pian
- Other names
- 康尔肾片
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))TGFB1 (Transforming growth factor Beta-1 proprotein)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on Kanger Shen Pian.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kanger Shen Pian.